한국어
Quantus

Sera Prognostics Class A

SERA · Nasdaq
$2.02+2.02%
2026-09-04 close

Sera Prognostics Class A last closed at $2.02 (+2.02%) on 2026-09-04. Signals today: Death cross. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
Close
데드크로스 · 0d 전

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Signal history

DateSignal+20 trading days

A record, not a prediction.

How this is calculated

"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

F
Overall: 상사,자본재 195/197 · top 99%
Factor composite · relative position in sector

PER — · PBR 1.63 — own-history percentile 32/100 · 55/100

Open self-history band
PER32/100
PBR55/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -11.87
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-11.87
Beneish M-Score
-5.82

No statistical flag

Sloan accrual
-25.78%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

1/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score1/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityDanger

매출 흑자인데 영업CF 적자 (OCF/매출 -18427%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업이익률 악화 (-13013.4% → -47577.9%, -34564.5%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

USAs of 2026-09-05

상사,자본재

This stock is in 상사,자본재: revenue rank 186 of 186, share 0%.

186 / 1860%revenue share

Who dominates this industry?

  1. 1Raytheon Technologies9.2%
  2. 2Lockheed Martin8.1%
  3. 3Boeing7.6%
  4. 4General Dynamics5.4%
  5. 5Northrop Grumman4.7%
  6. 6Sera Prognostics Class A0%

Concentration

DistributedCR3 24.9%
HHI 358186 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
11.85
Direction
확대
Level
보통
Years
10

Value lens

P90/P10
22.7
Median P/B
3.43
Level
넓음
n
172

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-47,577.9%
Interest coverage
-1,308.4x
Return on equity (ROE)
-68.8%

Operating margin −5pp

Operating loss
Interest coverageBase -1,308.4x adverse case -1,308.5x
Return on equity (ROE)Base -68.8% adverse case -76.7%

Revenue −15%

Interest coverage risk
Interest coverageBase -1,308.4x adverse case -1,112.1x
Return on equity (ROE)Base -68.8% adverse case -65.2%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -1,308.4x adverse case -70x
Return on equity (ROE)Base -68.8% adverse case -77.7%

Interest coverage limit

Already below the limit by 47,614.3pp

Interest coverage limit at an operating margin of 36.4%

Interest expense coverage threshold

Connections

AI-extracted related companies · for reference

Customers
Mayo Clinic LaboratoriesQuest DiagnosticsPrice comovement r=0.02 (1 year)
🔗 See in the full market map →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About Sera Prognostics Class A
What technical signals does Sera Prognostics Class A (SERA) have?
Sera Prognostics Class A current technical signals: death cross (5_20, 0d ago).
Is Sera Prognostics Class A a cup-and-handle pattern?
No. Sera Prognostics Class A has no valid cup-and-handle signal right now.
What are Sera Prognostics Class A's financials and valuation?
Sera Prognostics Class A's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy